Does RIPRETINIB Cause Melanocytic naevus? 34 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 34 reports of Melanocytic naevus have been filed in association with RIPRETINIB (QINLOCK). This represents 0.8% of all adverse event reports for RIPRETINIB.
34
Reports of Melanocytic naevus with RIPRETINIB
0.8%
of all RIPRETINIB reports
0
Deaths
3
Hospitalizations
How Dangerous Is Melanocytic naevus From RIPRETINIB?
Of the 34 reports, 3 (8.8%) required hospitalization.
Is Melanocytic naevus Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIPRETINIB. However, 34 reports have been filed with the FAERS database.
What Other Side Effects Does RIPRETINIB Cause?
Fatigue (582)
Alopecia (517)
Extra dose administered (357)
Death (356)
Underdose (345)
Nausea (292)
Drug ineffective (291)
Disease progression (290)
Hospitalisation (280)
Neoplasm progression (263)
What Other Drugs Cause Melanocytic naevus?
ADALIMUMAB (525)
FINGOLIMOD (338)
SECUKINUMAB (133)
METHOTREXATE (116)
ETANERCEPT (108)
RISANKIZUMAB-RZAA (89)
VEMURAFENIB (85)
INFLIXIMAB (84)
LENALIDOMIDE (69)
VALSARTAN (63)
Which RIPRETINIB Alternatives Have Lower Melanocytic naevus Risk?
RIPRETINIB vs RISANKIZUMAB
RIPRETINIB vs RISANKIZUMAB-RZAA
RIPRETINIB vs RISDIPLAM
RIPRETINIB vs RISEDRONATE
RIPRETINIB vs RISEDRONIC ACID